Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, De Caestecker M, Lin K (2004) Mol Cell 15: 813-23 Role of transforming growth factor-beta signaling in cancer. de Caestecker MP, Piek E, Roberts AB (2000) J Natl Cancer Inst 92: 1388-402 Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling. Chen X, Wang H, Liao HJ, Hu W, Gewin L, Mernaugh G, Zhang S, Zhang ZY, Vega-Montoto L, Vanacore RM, Fässler R, Zent R, Pozzi A (2014) J Clin Invest 124: 3295-310 Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB, Lechleider RJ (1998) Genes Dev 12: 1587-92 NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D (2005) Circ Res 97: 900-7 The histone demethylase Jmjd3 sequentially associates with the transcription factors Tbx3 and Eomes to drive endoderm differentiation. Kartikasari AE, Zhou JX, Kanji MS, Chan DN, Sinha A, Grapin-Botton A, Magnuson MA, Lowry WE, Bhushan A (2013) EMBO J 32: 1393-408 Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans. Kawasaki K, Freimuth J, Meyer DS, Lee MM, Tochimoto-Okamoto A, Benzinou M, Clermont FF, Wu G, Roy R, Letteboer TG, Ploos van Amstel JK, Giraud S, Dupuis-Girod S, Lesca G, Westermann CJ, Coffey RJ, Akhurst RJ (2014) Proc Natl Acad Sci U S A 111: 7723-8 Renal bone morphogenetic protein-7 protects against diabetic nephropathy. Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, Hirschberg R (2006) J Am Soc Nephrol 17: 2504-12 EGFR signaling promotes TGFβ-dependent renal fibrosis. Chen J, Chen JK, Nagai K, Plieth D, Tan M, Lee TC, Threadgill DW, Neilson EG, Harris RC (2012) J Am Soc Nephrol 23: 215-24 The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC, de Caestecker MP, Schnaper HW (1999) Kidney Int 56: 1354-65 The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Rojas A, Meherem S, Kim YH, Washington MK, Willis JE, Markowitz SD, Grady WM (2008) Int J Cancer 123: 14-21 Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Hayashida T, Decaestecker M, Schnaper HW (2003) FASEB J 17: 1576-8 Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Phillips JA, Poling JS, Phillips CA, Stanton KC, Austin ED, Cogan JD, Wheeler L, Yu C, Newman JH, Dietz HC, Loyd JE (2008) Genet Med 10: 359-65 STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Datta PK, Moses HL (2000) Mol Cell Biol 20: 3157-67 Smad7 induces hepatic metastasis in colorectal cancer. Halder SK, Rachakonda G, Deane NG, Datta PK (2008) Br J Cancer 99: 957-65 Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study. Su Y, Cai H, Zheng Y, Qiu Q, Lu W, Shu XO, Cai Q (2016) Am J Epidemiol 184: 501-509 Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. Engel ME, McDonnell MA, Law BK, Moses HL (1999) J Biol Chem 274: 37413-20 Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) J Biol Chem 275: 36803-10 Convergence of p53 and transforming growth factor beta (TGFbeta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells. Wang SE, Narasanna A, Whitell CW, Wu FY, Friedman DB, Arteaga CL (2007) J Biol Chem 282: 5661-9 The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. de Caestecker MP, Yahata T, Wang D, Parks WT, Huang S, Hill CS, Shioda T, Roberts AB, Lechleider RJ (2000) J Biol Chem 275: 2115-22 Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH (2005) Am J Pathol 167: 409-17 Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB (2003) Am J Pathol 163: 1261-73 Increased pSmad2 expression and cytoplasmic predominant presence of TGF-βRII in breast cancer tissue are associated with poor prognosis: results from the Shanghai Breast Cancer Study. Qiu Q, Su Y, Zheng Y, Cai H, Wu S, Lu W, Zheng W, Shu XO, Cai Q (2015) Breast Cancer Res Treat 149: 467-77 TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Samarakoon R, Overstreet JM, Higgins PJ (2013) Cell Signal 25: 264-8 Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species. Samarakoon R, Dobberfuhl AD, Cooley C, Overstreet JM, Patel S, Goldschmeding R, Meldrum KK, Higgins PJ (2013) Cell Signal 25: 2198-209 Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling. Ding ZY, Jin GN, Liang HF, Wang W, Chen WX, Datta PK, Zhang MZ, Zhang B, Chen XP (2013) Cell Signal 25: 1981-92 Mesendoderm induction and reversal of left-right pattern by mouse Gdf1, a Vg1-related gene. Wall NA, Craig EJ, Labosky PA, Kessler DS (2000) Dev Biol 227: 495-509 Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors. Mignemi NA, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Correa H, Coffin CM, Black JO, Yi Y, Halpern JL, Holt GE, Schwartz HS, Schoenecker JG, Cates JM (2012) Cancer Sci 103: 2173-80 Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation. Berger DH, Feng XH, Yao J, Saha D, Beauchamp RD, Lin X (2002) Surgery 132: 310-6 A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. Brown KA, Pietenpol JA, Moses HL (2007) J Cell Biochem 101: 9-33 Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. Brown KA, Ham AJ, Clark CN, Meller N, Law BK, Chytil A, Cheng N, Pietenpol JA, Moses HL (2008) J Cell Biochem 105: 596-611 TGF-beta1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors. Law AK, Gupta D, Levy S, Wallace DC, McKeon RJ, Buck CR (2004) BMC Neurosci 5: 1
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.